Scarica l'app Stockscreener
71.30
2.76%
-2.02
Precedente Chiudi:
$73.32
Aprire:
$73.33
Volume 24 ore:
105.06K
Relative Volume:
0.64
Capitalizzazione di mercato:
$788.55M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-2.52%
1M Prestazione:
+25.77%
6M Prestazione:
+168.45%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$70.55
$75.52
Intervallo di 1 settimana:
$70.55
$77.77
Portata 52W:
$11.17
$77.77
Palvella Therapeutics Inc Stock (PVLA) Company Profile
Nome
Palvella Therapeutics Inc
Settore
Industria
Telefono
(484) 253-1461
Indirizzo
125 STRAFFORD AVE, WAYNE
Confronta PVLA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PVLA
Palvella Therapeutics Inc
|
71.30 | 836.72M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.63 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.00 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.69 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.18 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.03 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Palvella Therapeutics Inc Stock (PVLA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-09 | Iniziato | Oppenheimer | Outperform |
| 2025-08-06 | Iniziato | Raymond James | Outperform |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-04-09 | Iniziato | Chardan Capital Markets | Buy |
| 2025-03-26 | Iniziato | Stifel | Buy |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2025-02-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-02-05 | Iniziato | TD Cowen | Buy |
| 2024-12-26 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-03-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-07-30 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-05-14 | Iniziato | Robert W. Baird | Outperform |
| 2018-03-19 | Iniziato | Evercore ISI | Outperform |
| 2018-03-19 | Iniziato | Jefferies | Buy |
| 2018-01-16 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-30 | Iniziato | Rodman & Renshaw | Buy |
| 2016-08-05 | Ripresa | ROTH Capital | Buy |
| 2015-08-12 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-07-27 | Iniziato | Oppenheimer | Outperform |
| 2015-07-22 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Palvella Therapeutics Inc Borsa (PVLA) Ultime notizie
Can Palvella Therapeutics Inc. stock rebound after recent weaknessQuarterly Market Summary & Weekly Chart Analysis and Trade Guides - newser.com
Can Palvella Therapeutics Inc. stock maintain growth trajectoryInsider Buying & Long-Term Capital Growth Strategies - newser.com
Multi factor analysis applied to Palvella Therapeutics Inc.Quarterly Profit Review & Target Return Focused Stock Picks - newser.com
Will a bounce in Palvella Therapeutics Inc. offer an exitWeekly Market Report & Weekly High Conviction Trade Ideas - newser.com
Trend analysis for Palvella Therapeutics Inc. this weekQuarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
Is Palvella Therapeutics Inc. (PI6) stock a good hedge against inflationMarket Activity Recap & Free Fast Gain Swing Trade Alerts - newser.com
How Palvella Therapeutics Inc. stock performs in stagflationQuarterly Portfolio Report & Fast Momentum Entry Tips - newser.com
Tools to monitor Palvella Therapeutics Inc. recovery probabilityJuly 2025 Sentiment & Accurate Buy Signal Notifications - newser.com
Why Palvella Therapeutics Inc. (PI6) stock is favored by hedge funds2025 Market Overview & Fast Moving Stock Trade Plans - newser.com
Can Palvella Therapeutics Inc. stock withstand economic slowdownJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
How institutional ownership impacts Palvella Therapeutics Inc. stockJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
Published on: 2025-10-21 16:43:34 - newser.com
Real time social sentiment graph for Palvella Therapeutics Inc.Weekly Stock Analysis & Community Consensus Picks - newser.com
Is Palvella Therapeutics Inc. meeting your algorithmic filter criteriaQuarterly Earnings Summary & Detailed Earnings Play Strategies - newser.com
Published on: 2025-10-21 06:40:39 - newser.com
What MACD and RSI say about Palvella Therapeutics Inc.Analyst Upgrade & Risk Controlled Daily Trade Plans - newser.com
Palvella Therapeutics Receives Second Year of FDA Grant Funding for Phase 3 SELVA Trial - MyChesCo
Published on: 2025-10-20 19:30:03 - newser.com
Why global investors buy Palvella Therapeutics Inc. (PI6) stockQuarterly Portfolio Review & Verified Technical Signals - newser.com
Reversal indicators forming on Palvella Therapeutics Inc. stockWeekly Gains Summary & Detailed Earnings Play Strategies - newser.com
Earnings Recap: Is Palvella Therapeutics Inc. (PI6) stock a contrarian opportunity2025 Key Lessons & Precise Buy Zone Tips - nchmf.gov.vn
Ideas Watch: Will Palvella Therapeutics Inc. stock outperform value stocks2025 Technical Patterns & Daily Growth Stock Tips - nchmf.gov.vn
Palvella Therapeutics Inc Azioni (PVLA) Dati Finanziari
Non sono disponibili dati finanziari per Palvella Therapeutics Inc (PVLA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.03%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):